Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hematologic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT02851472
What this trial is testing

Prevention of Transfusion Related Acute Gut Injury (TRAGI) in Extremely Low Gestational Age Neonates (ELGANs) Using iNO

Who this might be right for
Anemia
New York Medical College 50
Early research (Phase 1)Study completedNCT00006239
What this trial is testing

Phenylbutyrate and Tretinoin in Treating Patients With Hematologic Cancer

Who this might be right for
LeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Diseases
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Not applicableStudy completedNCT00267475
What this trial is testing

Data Bank for Eosinophilic Disorders

Who this might be right for
Eosinophilic EsophagitisGastritisEnteritis+2 more
Marc Rothenberg 500
Testing effectiveness (Phase 2)Study completedNCT04742101
What this trial is testing

Phase I/II Trial of S65487 Plus Azacitidine in Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
Institut de Recherches Internationales Servier 57
Not applicableStudy completedNCT04710212
What this trial is testing

Screening for Colonization With Resistant Enterobacterales in Neutropenic Patients With Hematologic Malignancies

Who this might be right for
Hematologic MalignancyLeukemia, AcuteNeutropenia+1 more
Duke University 168
Early research (Phase 1)UnknownNCT05731219
What this trial is testing

UTAA06 Injection in the Treatment of Relapsed/Refractory Acute Myeloid Leukemia

Who this might be right for
Relapsed/Refractory Acute Myeloid Leukemia
PersonGen BioTherapeutics (Suzhou) Co., Ltd. 18
Not applicableStudy completedNCT04816630
What this trial is testing

Feasibility Study of Hematology Parameters in COVID-19 Disease

Who this might be right for
Covid19SepsisAdults+1 more
Beckman Coulter, Inc. 32
Not applicableLooking for participantsNCT00662090
What this trial is testing

Study for Epidemiology and Characterization of Myelodysplastic Syndromes (MDS) and Juvenile Myelomonocytic Leucemia (JMML) in Childhood

Who this might be right for
Myelodysplastic SyndromesJuvenile Myelomonocytic Leukemia
University Hospital Freiburg 260
Not applicableStudy completedNCT00515710
What this trial is testing

LTFU for Gene Transfer Subjects With Hemophilia B

Who this might be right for
Hemophilia B
Spark Therapeutics, Inc. 4
Early research (Phase 1)Study completedNCT01629082
What this trial is testing

Clofarabine Followed By Lenalidomide for High-Risk Myelodysplastic Syndromes and Acute Myeloid Leukemia

Who this might be right for
Myeldysplastic Syndrome (MDS)Chronic Myelomonocytic LeukemiaBone Marrow Diseases+2 more
National Heart, Lung, and Blood Institute (NHLBI) 4
Not applicableLooking for participantsNCT04466059
What this trial is testing

Better Leukemia Diagnostics Through AI (BELUGA)

Who this might be right for
Hematologic MalignancyLeukemiaMinimal Residual Disease+2 more
Munich Leukemia Laboratory 25,000
Not applicableUnknownNCT00810680
What this trial is testing

Study of Efficacy and Safety of Valproic Acid in Chronic Lymphocytic Leukemia (CLL)

Who this might be right for
Chronic Lymphocytic Leukemia
All India Institute of Medical Sciences 10
Early research (Phase 1)Study completedNCT05987696
What this trial is testing

Natural Killer(NK) Cell Therapy in Acute Myeloid Leukemia

Who this might be right for
AML, AdultMinimal Residual Disease
Institute of Hematology & Blood Diseases Hospital, China 2
Not applicableStudy completedNCT02511769
What this trial is testing

Web-MAP Intervention for Youth With Sickle Cell Disease

Who this might be right for
Sickle Cell Disease
Connecticut Children's Medical Center 42
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07714213
What this trial is testing

Post-acute Infectious Syndrome - Aripiprazole Symptom Evaluation (PAIS-AriSE)

Who this might be right for
Post-acute Infectious Syndrome (PAIS)Post-COVID-19 Condition (PCC or Long COVID)
Christiana Franke 138
Testing effectiveness (Phase 2)Looking for participantsNCT06672146
What this trial is testing

Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)

Who this might be right for
Acute Myeloid Leukemia
National Cancer Institute (NCI) 93
Testing effectiveness (Phase 2)Active Not RecruitingNCT02782546
What this trial is testing

Cytokine Induced Memory-like NK Cell Adoptive Therapy After Haploidentical Donor Hematopoietic Cell Transplantation

Who this might be right for
Acute Myeloid Leukemia
Washington University School of Medicine 60
Not applicableLooking for participantsNCT06945042
What this trial is testing

ONC-LEUK-2406: The Impact of Systematic Financial Navigation in Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
Wake Forest University Health Sciences 120
Not applicableNot Yet RecruitingNCT06090786
What this trial is testing

Kinetics and Impact on Survival of MRD in AML Patients Receiving Azacitidine and Venetoclax

Who this might be right for
AML, AdultMinimal Residual Disease
Gruppo Italiano Malattie EMatologiche dell'Adulto 225
Testing effectiveness (Phase 2)UnknownNCT03992170
What this trial is testing

Study of Daratumumab in Multiple Myeloma (MM) Patients in >VGPR/MRD-positive

Who this might be right for
Myeloma Multiple
Azienda Ospedaliera Universitaria Senese 50
Next Page